机构:
John Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford, EnglandJohn Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford, England
Appay, V
[1
]
Hansasuta, P
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford, England
Hansasuta, P
Sutton, J
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford, England
Sutton, J
Schrier, RD
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford, England
Schrier, RD
Wong, JK
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford, England
Wong, JK
Furtado, M
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford, England
Furtado, M
Havlir, DV
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford, England
Havlir, DV
Wolinsky, SM
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford, England
Wolinsky, SM
McMichael, AJ
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford, England
McMichael, AJ
Richman, DD
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford, England
Richman, DD
Rowland-Jones, SL
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford, England
Rowland-Jones, SL
Spinha, CA
论文数: 0引用数: 0
h-index: 0
机构:John Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford, England
Spinha, CA
机构:
[1] John Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford, England
[2] Univ Calif San Diego, La Jolla, CA 92093 USA
[3] VA San Diego Healthcare Syst, La Jolla, CA USA
cytotoxic T lymphocytes;
CD4+;
HIV-1;
nef;
anti-retroviral therapy;
tetramers;
D O I:
10.1097/00002030-200201250-00004
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
Design: Antiretroviral therapy (ART) currently represents the best way to avert the lethal consequences of chronic persistent HIV-1 infection. It leads to significant reductions of plasma viremia, often to undetectable levels, but it can also be linked with the reduction and disappearance of detectable HIV-specific CD8 T-cell responses. Results: Here we describe a group of patients in whom ongoing replication of HIV, particularly transcription of Nef mRNA species, was detected despite prolonged and clinically successful antiretroviral treatment. Modest, but significant, numbers of HIV-specific CD8 T cells and CD4 T-cell responses were found in these subjects, with the strongest responses directed towards Nef epitopes. Detailed phenotypic analysis of the HIV-specific CD8 cells demonstrated low perforin levels and persistent expression of CD27, a phenotype associated with incomplete differentiation of cytotoxic T lymphocytes (CTL). Conclusion: This immature CTL phenotype has been described previously in association with chronic HIV disease, but its continued persistence is surprising in the setting of prolonged viral suppression on therapy and the presence of HIV-specific CD4 cell activity. (C) 2002 Lippincott Williams Wilkins.
机构:
John Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DS, EnglandJohn Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DS, England
McMichael, AJ
Rowland-Jones, SL
论文数: 0引用数: 0
h-index: 0
机构:
John Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DS, EnglandJohn Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DS, England
机构:
John Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DS, EnglandJohn Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DS, England
McMichael, AJ
Rowland-Jones, SL
论文数: 0引用数: 0
h-index: 0
机构:
John Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DS, EnglandJohn Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DS, England